We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00400738
Recruitment Status : Completed
First Posted : November 17, 2006
Last Update Posted : April 5, 2012
Sponsor:
Collaborators:
Roche Pharma AG
International Antiviral Therapy Evaluation Center
Kirby Institute
Information provided by:
The HIV Netherlands Australia Thailand Research Collaboration

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2006
  Study Completion Date : December 2006